Meanwhile, the homing ability of TIL to tumor sites was confirmed by the low circulating frequency of TILs on day 40 (Fig. 1B), as well as the co-localization of anti-CD8 and anti-panCK (Fig. 1C). This evidence concerns the gene CD8A and neoplasm.